Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SCHERING-PLOUGH

(SGP)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about SCHERING-PLOUGH
2009SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India
PR
2009SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary En..
PR
2009SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regard..
PR
2009SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices
PR
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Third Quarter
PR
2009SCHERING-PLOUGH : Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Proof of Con..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast For 2009 Third Quarter Earnings
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcu..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Convertible ..
PR
2009SCHERING-PLOUGH : Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Stu..
PR
2009SCHERING-PLOUGH : Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse..
PR
2009SCHERING-PLOUGH : New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their ..
PR
2009SCHERING-PLOUGH : Announces Two European Filings
PR
2009SCHERING-PLOUGH : ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) ..
PR
2009SCHERING-PLOUGH : Announces Resolution of Litigations on U.S. Marketing of Generic Forms o..
PR
2009SCHERING-PLOUGH : Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
PR
2009SCHERING-PLOUGH : PTC Therapeutics Announces Achievement of Major Milestone in Schering-Pl..
PR
2009SCHERING-PLOUGH : Shareholders Approve Merger With Merck
PR
2009SCHERING-PLOUGH : to Webcast Special Meeting of Shareholders
PR
2009SCHERING-PLOUGH : Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Actio..
PR
2009SCHERING-PLOUGH : /C O R R E C T I O N -- Schering-Plough Corporation/
PR
2009SCHERING-PLOUGH : Reports Proposed Settlement in Litigation Involving Planned Merger with ..
PR
2009SCHERING-PLOUGH : Schering profit rises
RE
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Second Quarter
PR
2009SCHERING-PLOUGH : Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
PR
2009SCHERING-PLOUGH : REMERON(R) Now Approved in Japan for the Treatment of Depression in Adul..
PR
2009SCHERING-PLOUGH : ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast for 2009 Second Quarter Earnings
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Mon..
PR
2009SCHERING-PLOUGH CP COM USD0.50 : Schering-Plough Declares Quarterly Dividends on Common Sh..
PR
2009SCHERING-PLOUGH CP COM USD0.50 : The New York Yankees' Mark Teixeira, National Foundation ..
PR
2009SCHERING-PLOUGH : Announces European Filing of SYCREST(R) (asenapine) for the Treatment of..
PR
2009SCHERING-PLOUGH : Critical Alerts for GS, SGP, GPS, PALM, and KWK Released by Seven Summit..
PR
2009SCHERING-PLOUGH : Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifung..
PR
2009SCHERING-PLOUGH : Announces Changes to its Global Collaboration with Novartis to Develop C..
PR
2009SCHERING-PLOUGH : Schedules Webcast For Annual Meeting of Shareholders
PR
2009SCHERING-PLOUGH : Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Larges..
PR
2009SCHERING-PLOUGH : Highlights Hepatitis C Clinical Data Presentations at the European Assoc..
PR
2009SCHERING-PLOUGH : profit beats views; cost cuts help
RE
2009SCHERING-PLOUGH : Reports Financial Results for 2009 First Quarter
PR
2009SCHERING-PLOUGH : Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumato..
PR
2009SCHERING-PLOUGH : Video: CLARITIN Partners with NASCAR Driver Carl Edwards to Educate Mot..
PR
2009SCHERING-PLOUGH : Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza ..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast for 2009 First Quarter Earnings
PR
2009SCHERING-PLOUGH : FDA Approves an Expanded Indication for Peginterferon-Based Combination ..
PR
2009SCHERING-PLOUGH : Withdraws From Barclays Capital Global Healthcare Conference
PR
2009SCHERING-PLOUGH : to Webcast Presentation at Barclays Capital Global Healthcare Conference
PR
2009SCHERING-PLOUGH : European Commission and United States Food and Drug Administration (FDA)..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentl..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Convertible ..
PR
2009SCHERING-PLOUGH : Announces Collaboration With World Health Organization to Provide Access..
PR
2009SCHERING-PLOUGH : Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatme..
PR
2009SCHERING-PLOUGH : Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Car..
PR
2009SCHERING-PLOUGH : Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch C..
PR
2009SCHERING-PLOUGH : Selects Benefit Advocates for Health Advocacy
PR
2009SCHERING-PLOUGH : New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
PR
2009SCHERING-PLOUGH : U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in ..
PR
2009SCHERING-PLOUGH : to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
PR
2009SCHERING-PLOUGH : Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Y..
PR
2008SCHERING-PLOUGH : Announces European Submission of Fertility Medicine Corifollitropin Alfa
PR
2008SCHERING-PLOUGH : Provides Update on Dividend Payment Date for Mandatory Convertible Prefe..
PR
2008SCHERING-PLOUGH : Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Thera..
PR
2008SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convert..
PR
2008SCHERING-PLOUGH : CHMP Recommends Approval in the European Union (EU) for New Options for ..
PR
2008SCHERING-PLOUGH : Highlights R&D Pipeline Progress, Innovation and Breadth of Research Pro..
PR
2008SCHERING-PLOUGH : Provides Update on Boceprevir Clinical Development and Introduces Potent..
PR
2008SCHERING-PLOUGH : Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Tria..
PR
2008SCHERING-PLOUGH : Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating..
PR
2008SCHERING-PLOUGH : to Webcast R&D Update Meeting
PR
2008SCHERING-PLOUGH : to Appeal Jury Decision in Missouri Reimbursement Case
PR
2008SCHERING-PLOUGH : Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Vir..
PR
2008SCHERING-PLOUGH : Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prev..
PR
2008SCHERING-PLOUGH : Schering beats forecast, as Vytorin falls
RE
1  2Next
Upcoming sector events